Chemren Bio-Engineering Co., Ltd.

PCI-32765

PCI-32765

Description of:PCI-32765
PCI-32765 is highly active and well tolerated in CLL/SLL pts irrespective of high risk genomic abnormalities. Although...
More>>
SB-431542

SB-431542

Description of:SB-431542
SB-431542 is potent and selective inhibitor of the transforming growth factor-β (TGF-β) type I receptor acti...
More>>
AEE788

AEE788

Description of:AEE788
AEE788 demonstrated antiproliferative activity against a range of EGFR and ErbB2-overexpressing cell lines and inhibited ...
More>>
OSI930

OSI930

Description of:OSI 930
OSI-930 is designed to target both cancer cell proliferation and blood vessel growth (angiogenesis) in selected tumors.<...
More>>
Cediranib(AZD2171)

Cediranib(AZD2171)

Description of:Cediranib (AZD2171)
Cediranib (AZD2171) is a once-daily oral tyrosine kinase inhibitor that targets vascular endothelial growth ...
More>>
MP470

MP470

Description of:MP470 
MP470 reduced c-Met phosphorylation and enhanced radiation-induced cell kill by 0.4 logs in SF767 cells. Cells pretr...
More>>
Motesanib Diphosphate

Motesanib Diphosphate

Description of:Motesanib Diphosphate
Motesanib Diphosphate potently inhibited VEGF-induced but not bFGF-induced proliferation of HUVECs with IC...
More>>
RAF265(CHIR-265)

RAF265(CHIR-265)

Description of:RAF265(CHIR-265)
RAF is a key component of the RAS/RAF/MEK/ERK signal-transduction pathway, which controls cell proliferation, d...
More>>
Sunitinib Malate(SU 11248)

Sunitinib Malate(SU 11248)

Description of:Sunitinib Malate(SU 11248)
Sunitinib dose-dependently inhibited stem cell factor (SCF)-induced phosphotyrosine levels on KIT (IC...
More>>
PD173074

PD173074

Description of:PD173074
PD173074 is a potent ATP-competitive, reversible FGFR and VEGFR inhibitor with IC50 of 5, 21.5 and ~100 nM for FGFR3, F...
More>>
Total: 130 Page: 6 / 13 First ←Previous Next→ End